Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry
Format: | Article |
---|---|
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/1/e001461corr1.full |
Similar Items
-
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry
by: Valderílio Feijó Azevedo, et al.
Published: (2021-04-01) -
A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study
by: Marques, Claudia, et al.
Published: (2020-12-01) -
Reuma.pt/vasculitis – the Portuguese vasculitis registry
by: Cristina Ponte, et al.
Published: (2020-05-01) -
Reuma.pt contribution to the knowledge of immune-mediated systemic rheumatic diseases
by: Maria José Santos, et al.
Published: (2017-07-01) -
EpiReumaPt- the study of Rheumatic and Musculoskeletal diseases in Portugal: A detailed view of the methodology
by: Ana M Rodrigues, et al.
Published: (2015-04-01)